MYC and hepatocellular carcinoma: Yin et al. found that c-MYC regulated by the ID1/Wnt/β-catenin axis binds to the promoter of G6PD and promotes G6PD transcription and encourages tumor proliferation and oxaliplatin chemoresistance in hepatocellular carcinoma (HCC) [45].